These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6242640)

  • 41. [Aspects of treatment with immunosuppressive agents in ophthalmology].
    Micşa MV; Weinberg J; Ciocan I; Zapolschi D; Popovici S
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):233-5. PubMed ID: 6460300
    [No Abstract]   [Full Text] [Related]  

  • 42. Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%.
    Oldhoff JM; Knol EF; Laaper-Ertmann M; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Allergy; 2006 May; 61(5):622-8. PubMed ID: 16629794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologic agents in experimental autoimmune uveitis.
    Giuliari GP; Sadaka A; Hinkle DM
    Int Ophthalmol; 2014 Feb; 34(1):145-56. PubMed ID: 23494482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cytokines in experimental and clinical uveitis.
    Singh VK; Rai G; Agarwal SS
    Indian J Ophthalmol; 2001 Jun; 49(2):81-90. PubMed ID: 15884511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental Hartmannella optic neuritis and uveitis.
    Schlaegel TF; Culbertson CG
    Ann Ophthalmol; 1972 Feb; 4(2):103-6 passim. PubMed ID: 5058394
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
    Roblin X; Phelip JM
    Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 50. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re: Triamcinolone acetonide in ocular therapeutics.
    Rishi P; Sharma T; Rishi E
    Surv Ophthalmol; 2008; 53(2):184; author reply 184. PubMed ID: 18348883
    [No Abstract]   [Full Text] [Related]  

  • 52. [Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
    Liang HC; Hui YN; Cai YS
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):122-4. PubMed ID: 8001444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunologic diseases: their experimental pattern and pharmacotherapy].
    Zak A
    Postepy Hig Med Dosw; 1971; 25(3):415-31. PubMed ID: 4105861
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of cyclosporine in ocular inflammatory disorders.
    Nussenblatt RB
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):114-21. PubMed ID: 3289201
    [No Abstract]   [Full Text] [Related]  

  • 55. Blinded by lack of evidence.
    Ramanan AV; Dick AD
    Rheumatology (Oxford); 2013 May; 52(5):765-6. PubMed ID: 23221329
    [No Abstract]   [Full Text] [Related]  

  • 56. Discussion on immunosuppressive therapy.
    Mod Probl Ophthalmol; 1976; 16():324-7. PubMed ID: 1250237
    [No Abstract]   [Full Text] [Related]  

  • 57. Possible molecular mechanisms to account for the efficacy of allopurinol against experimental autoimmune uveitis.
    Namazi MR
    Int Immunopharmacol; 2004 Jan; 4(1):161-2. PubMed ID: 14975372
    [No Abstract]   [Full Text] [Related]  

  • 58. Granulomatous tattoo reaction with associated uveitis successfully treated with methotrexate.
    Maijer KI; van der Bent SAS; Vercoutere W; Rustemeyer T
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e338-e339. PubMed ID: 29419907
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of immunosuppressive therapy on experimental uveitis in the rat].
    Niederer W
    Ger Med Mon; 1968 Aug; 13(8):393. PubMed ID: 5682422
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of several immunosuppressive agents on experimental allergic uveitis (author's transl)].
    Yamamoto K
    Nippon Ganka Gakkai Zasshi; 1974 Jul; 78(7):420-8. PubMed ID: 4474805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.